BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pfizer - Centers of Therapeutic Innovation 

1700 Owens Street

San Francisco  California  94158  U.S.A.
Phone: 415-852-6636 Fax: n/a


SEARCH JOBS


The Centers for Therapeutic Innovation unit is aimed at forging seamless, highly impactful ties between pharma and academia, thus enabling the accelerated translation of innovative findings to the clinic. Pfizer’s ambition is to bridge the gap translating early science into clinical applications, by, for the first time, allowing investigators access to Pfizer’s extensive libraries and proprietary screening and antibody development technologies. In addition, academic collaborators will have the support of internal Pfizer scientists who can help match Pfizer resources to key researcher needs. CTI offers a differentiated approach, the incentives, operating model, and goals of which are all designed to focus on achieving a positive Proof of Mechanism (PoM) study in humans.

Pfizer Centers for Therapeutic Innovation will consist of several laboratories which combine the expertise and innovation of both Pfizer colleagues dedicated to a specific function, as well as ~ 15 post-docs assigned to sponsored programs. This initiative represents a significant opportunity for leading academic investigators and institutions to enable the fast, efficient translation of novel, innovative science into clinical candidates, and – eventually – approved therapeutics. We believe that the combination of the operating, financial resource and scientific access model partly described above will bring more and more novel programs to the clinic, ultimately creating significant benefit for the patient, for investigators, and for institutions.


 Key Statistics


Email:
Ownership:

Web Site: Pfizer - Centers of Therapeutic Innovation
Employees:
Symbol: PFE
 









 Company News
Currently No News Articles